Bipolar Disorder Trial, Recruiting NCT06872398 Sponsor: Fondation FondaMental Condition: Bipolar Disorder
Back to Bipolar Disorder

Bipolar Disorder Trial, Recruiting

NCT06872398
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Bipolar Disorder (Type I, Type II, or a related type)
  • You have been in contact with mental health services at least once in the past year
  • You are between 18 and 65 years old
  • You have read and signed a form agreeing to take part in the study

Who may not be able to join:

  • You are planning to move to a different location within the next year
  • You have been diagnosed with a serious mental health condition in addition to bipolar disorder, such as schizophrenia or a related condition
  • You have severe difficulties with memory, thinking, or understanding (confirm with trial site)
  • You have a serious problem with alcohol or drug use, as measured by specific questionnaire scores (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marion LEBOYER, MD PhD, Fondation FondaMental

Phone: 0149813326

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fondation FondaMental
Registry
ClinicalTrials.gov
Start date
11 October 2024
Est. completion
1 December 2025

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Incidence of Metabolic Syndrome (MetS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov